Vasculox

Summary

As a St. Louis pharmaceutical biotechnology startup, Vasculox, Inc. develops groundbreaking treatments for individuals suffering from multiple cancers, pulmonary hypertension and other life-threatening conditions. In order to bring these vital therapies to market, Vasculox needed a strong online presence to partner with and inform investors, the medical community and patients.

Vasculox

Challenge

The biotech startup had already established a strong foundation in the industry with backing from the National Heart, Lung and Blood Institute (NHLBI), Biogenerator and Missouri Technology Corporation. But without an engaging website, Vasculox risked missing vital opportunities to engage their existing investors and draw new sources of funding and support for their potentially life-saving treatments.

Solution

NeuConcept collaborated with the leaders of Vasculox to develop and launch the biotech’s website.

The NeuConcept team:

Established a high-functioning, mobile-responsive site to engage and educate patients, the healthcare industry and investors.